WO2004110323A1 - Dispositif a emplatre - Google Patents
Dispositif a emplatre Download PDFInfo
- Publication number
- WO2004110323A1 WO2004110323A1 PCT/DE2003/001786 DE0301786W WO2004110323A1 WO 2004110323 A1 WO2004110323 A1 WO 2004110323A1 DE 0301786 W DE0301786 W DE 0301786W WO 2004110323 A1 WO2004110323 A1 WO 2004110323A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- opacity
- value
- contact layer
- dimensioned
- range
- Prior art date
Links
- 239000010410 layer Substances 0.000 claims abstract description 22
- 239000011241 protective layer Substances 0.000 claims abstract description 9
- 244000025254 Cannabis sativa Species 0.000 claims description 10
- 235000012766 Cannabis sativa ssp. sativa var. sativa Nutrition 0.000 claims description 10
- 235000012765 Cannabis sativa ssp. sativa var. spontanea Nutrition 0.000 claims description 10
- 235000009120 camo Nutrition 0.000 claims description 10
- 235000005607 chanvre indien Nutrition 0.000 claims description 10
- 239000011487 hemp Substances 0.000 claims description 10
- 239000011505 plaster Substances 0.000 claims description 10
- 239000000835 fiber Substances 0.000 claims description 9
- 239000000126 substance Substances 0.000 claims description 7
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 claims description 4
- 239000013543 active substance Substances 0.000 claims description 3
- 210000001124 body fluid Anatomy 0.000 claims description 3
- SNICXCGAKADSCV-JTQLQIEISA-N (-)-Nicotine Chemical compound CN1CCC[C@H]1C1=CC=CN=C1 SNICXCGAKADSCV-JTQLQIEISA-N 0.000 claims description 2
- FUFLCEKSBBHCMO-UHFFFAOYSA-N 11-dehydrocorticosterone Natural products O=C1CCC2(C)C3C(=O)CC(C)(C(CC4)C(=O)CO)C4C3CCC2=C1 FUFLCEKSBBHCMO-UHFFFAOYSA-N 0.000 claims description 2
- MFYSYFVPBJMHGN-ZPOLXVRWSA-N Cortisone Chemical compound O=C1CC[C@]2(C)[C@H]3C(=O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 MFYSYFVPBJMHGN-ZPOLXVRWSA-N 0.000 claims description 2
- MFYSYFVPBJMHGN-UHFFFAOYSA-N Cortisone Natural products O=C1CCC2(C)C3C(=O)CC(C)(C(CC4)(O)C(=O)CO)C4C3CCC2=C1 MFYSYFVPBJMHGN-UHFFFAOYSA-N 0.000 claims description 2
- 102000004877 Insulin Human genes 0.000 claims description 2
- 108090001061 Insulin Proteins 0.000 claims description 2
- 230000002745 absorbent Effects 0.000 claims description 2
- 239000002250 absorbent Substances 0.000 claims description 2
- 208000006673 asthma Diseases 0.000 claims description 2
- 229960004544 cortisone Drugs 0.000 claims description 2
- 229940125396 insulin Drugs 0.000 claims description 2
- 210000000653 nervous system Anatomy 0.000 claims description 2
- 229960002715 nicotine Drugs 0.000 claims description 2
- SNICXCGAKADSCV-UHFFFAOYSA-N nicotine Natural products CN1CCCC1C1=CC=CN=C1 SNICXCGAKADSCV-UHFFFAOYSA-N 0.000 claims description 2
- 208000037175 Travel-Related Illness Diseases 0.000 claims 1
- 239000010839 body fluid Substances 0.000 claims 1
- 201000003152 motion sickness Diseases 0.000 claims 1
- 230000005855 radiation Effects 0.000 abstract description 6
- 210000003491 skin Anatomy 0.000 description 10
- 238000000354 decomposition reaction Methods 0.000 description 5
- 230000000694 effects Effects 0.000 description 2
- 230000035876 healing Effects 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 210000002268 wool Anatomy 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/42—Use of materials characterised by their function or physical properties
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F13/02—Adhesive bandages or dressings
- A61F13/0203—Adhesive bandages or dressings with fluid retention members
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/42—Use of materials characterised by their function or physical properties
- A61L15/44—Medicaments
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F2013/00089—Wound bandages
- A61F2013/00153—Wound bandages coloured or with decoration pattern or printing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F2013/00089—Wound bandages
- A61F2013/00285—Wound bandages medication confinement
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F2013/00361—Plasters
- A61F2013/00365—Plasters use
- A61F2013/00387—Plasters use skin protection
- A61F2013/00391—Plasters use skin protection from irradiation, e.g. sun
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F2013/00361—Plasters
- A61F2013/00544—Plasters form or structure
- A61F2013/00646—Medication patches, e.g. transcutaneous
- A61F2013/00651—Medication patches, e.g. transcutaneous tapered, bevelled or chamfered
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
- A61L2300/22—Lipids, fatty acids, e.g. prostaglandins, oils, fats, waxes
- A61L2300/222—Steroids, e.g. corticosteroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/43—Hormones, e.g. dexamethasone
Definitions
- the invention relates to a plaster device for covering selected areas of the human skin, with a carrier layer having a surface and a
- a contact layer is provided, the underside of which comes into contact with a selected skin site.
- Plaster devices of the type mentioned above are used in the prior art, on the one hand to protect damaged areas of skin from mechanical effects from the outside and thereby promote a healing process.
- the known devices are used to bring epidermis permeable medically active substances into skin contact, so as to have a longer duration Period to ensure uniform delivery of the substances into the human body.
- the known plaster devices have the disadvantage that in the case of the former application, in particular in the area of exposed body parts effective protection against curative UV radiation of the sun is not guaranteed, and that in the case of the latter application the substances to be introduced into the human body not are safely protected from degradation caused by UV radiation of the sun and / or accelerated decomposition in the form of decomposition or oxidation.
- the object of the invention is therefore to provide a plaster device in which an effective protection against UV radiation of the sun is already guaranteed in the area of the surface of the carrier layer.
- the protective layer has an opacity with a value greater than 0.55.
- the protective layer has an opacity with a value greater than 0.55 achieves a device in which, on the one hand, in the area of exposed parts of the body effective protection against UV radiation which inhibits healing of the body Sun, and on the other hand, in the case where the patch device is provided for administering medically effective substances, the substances to be introduced into the human body are certainly provided a decomposition induced by UV radiation of the sun and / or accelerated decomposition in the form of decomposition or oxidation are protected.
- opacity of 1 ie non-transparency for light of any wavelength, is not sought for the reason, because this can be achieved technically only with a simultaneous gas impermeability, which is not desirable from a medical point of view.
- the opacity is defined here as that of a transparency inverse value between 0 and 1, where an opacity of 0 corresponds to 100 percent transparency and an opacity of 1 corresponds to 100 percent intransparency or complete absorption or reflection of light and UV rays.
- the value of the opacity is dimensioned in the range between 0.6 and 0.9.
- the value of the opacity depending on the application, is between 0.65 and 0.85, between 0.65 and 0.8, between 0.7 and 0.85 or between 0.75 and 0.9.
- the respective opacity is preferably generated by a corresponding shading of the color brown.
- the contact layer is formed by fiber parts of the hemp shrub.
- the contact layer may alternatively be made of a conventional material such as wool or fleece and thereby be interspersed only with certain fiber parts of hemp shrubs and thus contain only a certain proportion, the fiber parts always always from the leaves or the Stems of hemp shrub may be formed.
- Hemp fibers or hemp components generally have the advantage of an anti-inflammatory and healing-promoting effect of the contact layer.
- the contact layer is designed to be hydrophilic for a first application for covering areas of skin in order to absorb bodily fluid escaping from an injured skin area.
- the contact layer is preferably provided as a reservoir for epidermis-permeable medically active substances to be delivered to intended skin sites.
- the reservoir contains, for example, a nicotine substitute, insulin, an asthma-effective cortisone or a substance that controls the vegetative nervous system for the control of travel diseases.
- Fig. 1 shows a first preferred embodiment of the device according to the invention in a view from above;
- FIG. 2 shows the preferred embodiment of the device according to the invention shown in FIG. 1 in a cross-sectional view
- FIG. Fig. 3 shows another preferred embodiment of the device according to the invention in a view from above;
- Fig. 5 shows a further preferred embodiment of the device according to the invention in a view from above.
- Fig. 6 shows a further preferred embodiment of the device according to the invention in a view from above.
- the plaster devices 100 according to the invention for covering selected areas of the human skin shown in FIGS. 1 to 6 comprise a carrier layer 110 having a surface 111 and a bottom surface 112, the surface 111 being provided with a protective layer, and being at least partially in the region of Bottom surface 112, a contact layer 120 is provided, the underside of which contacts a selected skin site.
- the protective layer has an essential to the invention an opacity with a value greater than 0.55. In the embodiments shown in the figures, the value of the opacity is in the range between 0.6 and 0.9, the respective opacity being produced by a corresponding shade of the color brown.
- the contact layer 120 of the illustrated invention is the contact layer 120 of the illustrated invention.
- Plaster devices 100 are formed entirely of fiber parts of the hemp shrub, the fiber parts of which
- the contact layer 120 is hydrophilically absorbent to absorb bodily fluids leaking from injured skin.
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Materials Engineering (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Medicinal Preparation (AREA)
- Media Introduction/Drainage Providing Device (AREA)
Abstract
L'invention concerne un dispositif à emplâtre (100) destiné à recouvrir des zones sélectionnées de la peau humaine, comprenant une couche support (110) présentant une surface (111) et une surface inférieure (112), ladite surface (111) comportant une couche protectrice, cependant qu'il est prévu, au moins partiellement dans la région de la surface inférieure (112), une couche de contact (120) dont la face inférieure entre en contact avec une zone sélectionnée de la peau. Une protection efficace contre le rayonnement UV solaire est obtenue dès qu'on se trouve dans la région de la surface (111) de la couche support (110), du fait que la couche protectrice présente une opacité d'une valeur supérieure à 0,55.
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP03817241A EP1680058A1 (fr) | 2003-06-02 | 2003-06-02 | Dispositif a emplatre |
PCT/DE2003/001786 WO2004110323A1 (fr) | 2003-06-02 | 2003-06-02 | Dispositif a emplatre |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/DE2003/001786 WO2004110323A1 (fr) | 2003-06-02 | 2003-06-02 | Dispositif a emplatre |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2004110323A1 true WO2004110323A1 (fr) | 2004-12-23 |
Family
ID=33546406
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/DE2003/001786 WO2004110323A1 (fr) | 2003-06-02 | 2003-06-02 | Dispositif a emplatre |
Country Status (2)
Country | Link |
---|---|
EP (1) | EP1680058A1 (fr) |
WO (1) | WO2004110323A1 (fr) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2005027859A3 (fr) * | 2003-09-23 | 2005-05-12 | Reed Gamble | Timbre |
Citations (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB439085A (en) * | 1935-02-06 | 1935-11-28 | Ernst Gelinsky | Improvements in or relating to dressings for wounds and the like |
US2905174A (en) * | 1957-09-27 | 1959-09-22 | Johnson & Johnson | Adhesive bandage |
US3156242A (en) * | 1962-03-29 | 1964-11-10 | Johnson & Johnson | Flexible absorbent sheet |
GB1071191A (en) * | 1963-12-24 | 1967-06-07 | Johnson & Johnson | Absorbent non-woven fibrous product |
US4161176A (en) * | 1977-04-05 | 1979-07-17 | Frederick Earl Harris, II | Color adaptable bandage |
DE3513526A1 (de) * | 1985-04-16 | 1986-10-16 | Hoechst Ag, 6230 Frankfurt | Dehaesiv ausgeruestete kunststoff-folie, verfahren zur herstellung der folie und ihre verwendung |
WO1993017647A1 (fr) * | 1992-03-05 | 1993-09-16 | Avery Dennison Corporation | Polymeres autoadhesifs en emulsion utilises dans des rubans adhesifs medicaux et des bandages |
EP0484543B1 (fr) * | 1990-04-24 | 1995-12-13 | Teijin Limited | Emplatre |
DE29517506U1 (de) * | 1995-11-04 | 1996-06-05 | Pirro, Michael, 66424 Homburg | Sonnenschutzpflaster selbstklebend |
US5631078A (en) * | 1995-10-30 | 1997-05-20 | Eastman Chemical Company | Films made from paper containing cellulose ester fiber |
DE29716589U1 (de) * | 1997-09-16 | 1997-11-27 | Evers, Henning, 23821 Rohlstorf | Pflaster |
DE19631848A1 (de) * | 1996-08-07 | 1998-02-12 | Wess Transporte | Schablone und Verfahren zum Erzeugen eines vergänglichen Motives auf der menschlichen Haut |
WO2001007096A1 (fr) * | 1999-07-28 | 2001-02-01 | Dardai Zoltan | Emplatre permettant d'introduire des compositions pharmaceutiques dans des organismes vivants |
US6224900B1 (en) * | 1986-08-28 | 2001-05-01 | Lts Lohmann Therapie-Systeme Gmbh & Co. Kg | Sealing bag for a transdermal therapeutic system |
WO2001091681A1 (fr) * | 2000-06-01 | 2001-12-06 | Ucb S.A. | Pansement pour plaie |
US6471988B1 (en) * | 1998-06-26 | 2002-10-29 | Medeikonos Ab | Device for protection against the sun and application of substance to the skin |
-
2003
- 2003-06-02 WO PCT/DE2003/001786 patent/WO2004110323A1/fr active Application Filing
- 2003-06-02 EP EP03817241A patent/EP1680058A1/fr not_active Withdrawn
Patent Citations (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB439085A (en) * | 1935-02-06 | 1935-11-28 | Ernst Gelinsky | Improvements in or relating to dressings for wounds and the like |
US2905174A (en) * | 1957-09-27 | 1959-09-22 | Johnson & Johnson | Adhesive bandage |
US3156242A (en) * | 1962-03-29 | 1964-11-10 | Johnson & Johnson | Flexible absorbent sheet |
GB1071191A (en) * | 1963-12-24 | 1967-06-07 | Johnson & Johnson | Absorbent non-woven fibrous product |
US4161176A (en) * | 1977-04-05 | 1979-07-17 | Frederick Earl Harris, II | Color adaptable bandage |
DE3513526A1 (de) * | 1985-04-16 | 1986-10-16 | Hoechst Ag, 6230 Frankfurt | Dehaesiv ausgeruestete kunststoff-folie, verfahren zur herstellung der folie und ihre verwendung |
US6224900B1 (en) * | 1986-08-28 | 2001-05-01 | Lts Lohmann Therapie-Systeme Gmbh & Co. Kg | Sealing bag for a transdermal therapeutic system |
EP0484543B1 (fr) * | 1990-04-24 | 1995-12-13 | Teijin Limited | Emplatre |
WO1993017647A1 (fr) * | 1992-03-05 | 1993-09-16 | Avery Dennison Corporation | Polymeres autoadhesifs en emulsion utilises dans des rubans adhesifs medicaux et des bandages |
US5631078A (en) * | 1995-10-30 | 1997-05-20 | Eastman Chemical Company | Films made from paper containing cellulose ester fiber |
DE29517506U1 (de) * | 1995-11-04 | 1996-06-05 | Pirro, Michael, 66424 Homburg | Sonnenschutzpflaster selbstklebend |
DE19631848A1 (de) * | 1996-08-07 | 1998-02-12 | Wess Transporte | Schablone und Verfahren zum Erzeugen eines vergänglichen Motives auf der menschlichen Haut |
DE29716589U1 (de) * | 1997-09-16 | 1997-11-27 | Evers, Henning, 23821 Rohlstorf | Pflaster |
US6471988B1 (en) * | 1998-06-26 | 2002-10-29 | Medeikonos Ab | Device for protection against the sun and application of substance to the skin |
WO2001007096A1 (fr) * | 1999-07-28 | 2001-02-01 | Dardai Zoltan | Emplatre permettant d'introduire des compositions pharmaceutiques dans des organismes vivants |
WO2001091681A1 (fr) * | 2000-06-01 | 2001-12-06 | Ucb S.A. | Pansement pour plaie |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2005027859A3 (fr) * | 2003-09-23 | 2005-05-12 | Reed Gamble | Timbre |
Also Published As
Publication number | Publication date |
---|---|
EP1680058A1 (fr) | 2006-07-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP3069578B1 (fr) | Appareil de traitement d'une surface corporelle d'un être vivant | |
EP0107051A2 (fr) | Matériau de recouvrement de plaie pour bandages ou compresses | |
DE9403161U1 (de) | Kanüle | |
DE102005043929B3 (de) | Vorrichtung zum Einbringen eines Wirkstoffs in die Haut | |
WO2004110323A1 (fr) | Dispositif a emplatre | |
DE3643153C2 (fr) | ||
CH677443A5 (fr) | ||
DE3202775A1 (de) | Adhaesions-pflaster und verfahren zur herstellung eines adhaesions-pflasters | |
DE20308636U1 (de) | Pflaster-Vorrichtung | |
WO2009106323A1 (fr) | Pansement | |
DE102020134781B4 (de) | Verbessertes Pflaster | |
DE29511982U1 (de) | Pflaster | |
EP0848959A2 (fr) | Produit thérapeutique humain pour le traitement et/ou la prophylaxie de maladies par des vapeurs d'huiles etherées | |
DE102008035848A1 (de) | Pflaster | |
DE10158424C2 (de) | Vorrichtung zum Behandeln von Insektenstichen | |
DE202018103970U1 (de) | Schlafhilfsvorrichtung | |
DE9014837U1 (de) | Einrichtung zur medizinischen Versorgung einer Schnittwunde | |
DE202020107505U1 (de) | Verbessertes Pflaster | |
DE10345665A1 (de) | Wundplaster | |
DE2817809C2 (de) | Gehörschutzstöpsel und Verfahren zu seiner Herstellung | |
DE1489693B1 (de) | Schutzvorrichtung zur Linderung der durch statischeElektrizitaet verursachten Schmerzen in einer Wunde oder auf der menschlichen E pidermis | |
DE202005021421U1 (de) | Vorrichtung zur intravasalen Laserblutbestrahlung | |
DE3233258A1 (de) | Verfahren zur bestimmung der wirksamkeit eines mittels auf der haut einer person, insbesondere zur bestimmung des lichtschutzfaktors eines sonnenschutzmittels | |
WO2019105631A1 (fr) | Pansement adhésif de fixation de canule | |
DE7817327U1 (de) | Testpflasterstreifen |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): JP US |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2003817241 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 2003817241 Country of ref document: EP |
|
NENP | Non-entry into the national phase |
Ref country code: JP |